Antibodies to interferon-like protein Zcyto21(IL29)

Details Antibodies to interferon-like protein Zcyto21(IL29) Antibodies to interferon-like protein Zcyto21(IL29)

2011-04-05

2011-04-05

Saoud, Christine J (Department: 1646)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

Blood proteins or globulins, e.g., proteoglycans, platelet...

C530S388100, C530S388150, C530S388700, C530S391100, C530S391300, C435S331000

Reexamination Certificate

active

07919595

ABSTRACT:
The present invention relates to polynucleotide and polypeptide molecules for Zcyto21, an interferon-like protein, which is most closely related to interferon-α at the amino acid sequence level. The present invention also includes antibodies to the Zcyto21 polypeptides, and methods of using the polynucleotides and polypeptides.

REFERENCES:
patent: 6927040 (2005-08-01), Sheppard et al.
patent: 7038032 (2006-05-01), Sheppard et al.
patent: 7135170 (2006-11-01), Klucher et al.
patent: 7157559 (2007-01-01), Brady et al.
patent: 7241870 (2007-07-01), Sheppard et al.
patent: 7252969 (2007-08-01), Sheppard et al.
patent: 7253261 (2007-08-01), Sheppard et al.
patent: 7445773 (2008-11-01), Sheppard et al.
patent: 7445913 (2008-11-01), Sheppard et al.
patent: 7446172 (2008-11-01), Sheppard et al.
patent: 7455993 (2008-11-01), Sheppard et al.
patent: 7462467 (2008-12-01), Sheppard et al.
patent: 7468423 (2008-12-01), Brady et al.
patent: 7479542 (2009-01-01), Brady et al.
patent: 7485699 (2009-02-01), Sheppard et al.
patent: 7485700 (2009-02-01), Sheppard et al.
patent: 7485701 (2009-02-01), Brady et al.
patent: 7485702 (2009-02-01), Brady et al.
patent: 7495077 (2009-02-01), Brady et al.
patent: 7495078 (2009-02-01), Brady et al.
patent: 7495079 (2009-02-01), Brady et al.
patent: 7498154 (2009-03-01), Sheppard et al.
patent: 7514536 (2009-04-01), Brady et al.
patent: 7517961 (2009-04-01), Brady et al.
patent: 7544779 (2009-06-01), Brady et al.
patent: 7582450 (2009-09-01), Brady et al.
patent: 7588918 (2009-09-01), Brady et al.
patent: 7588919 (2009-09-01), Brady et al.
patent: 7595174 (2009-09-01), Brady et al.
patent: 7608427 (2009-10-01), Brady et al.
patent: 7608428 (2009-10-01), Brady et al.
patent: 7629148 (2009-12-01), Brady et al.
patent: 7629149 (2009-12-01), Brady et al.
patent: 7638305 (2009-12-01), Brady et al.
patent: 7655222 (2010-02-01), Sheppard et al.
patent: 7655223 (2010-02-01), Sheppard et al.
patent: 7662589 (2010-02-01), Brady et al.
patent: 7662590 (2010-02-01), Brady et al.
patent: 7662927 (2010-02-01), Sheppard et al.
patent: 2008/0124299 (2008-05-01), Klucher et al.
patent: 2008/0279816 (2008-11-01), Brady et al.
patent: 2009/0263352 (2009-10-01), Klucher et al.
patent: 2009/0326204 (2009-12-01), Sheppard et al.
patent: 2010/0104531 (2010-04-01), Brady et al.
patent: 2010/0222266 (2010-09-01), Sheppard et al.
patent: 2010/0227813 (2010-09-01), Sheppard et al.
patent: 0 032 124 (1981-07-01), None
patent: 02/092762 (2002-11-01), None
patent: 03/066002 (2003-08-01), None
patent: WO 2009/149377 (2009-12-01), None
patent: 2010/045261 (2010-04-01), None
Adams et al., Accession No. T07139, 1993.
DOE Joint Genome Institute Stanford Human Genome Center, Accession No. AC011445, 1999.
Muzney et al., Accession No. AC0118477, 1999.
Sanger Centre Search Results, Accession No. AC011445, 2001.
University of California Santa Cruz database using Softberry, Inc. gene prediction software, Accession No. C19001084, 2001.
Scott et al., “The Pendred syndrome gene encodes a chloride-iodide transport protein,”Nature Genetics, 21:440-443, 1999.
Korba et al., “A cell culture assay for compounds which inhibit hepatitis B virus replication,”Antiviral Research 15:217-228, 1991.
Korba et al., “Use of a standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replication,”Antiviral Research19:55-70, 1992.
Kotenko et al., “IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex,”Nat. Immunol. 4(1):69-77, 2003.
Sheppard et al., “IL-28, Il-29 and their class II cytokine receptor IL-28R,”Nat. Immunol. 4(1):63-68, 2003.
Brack et al., “Molecular analysis of the human interferon-α gene family,”Gene15:379-394, 1981.
Klucher et al., U.S. Appl. No. 12/608,840, filed Oct. 29, 2009.
Sheppard et al., U.S. Appl. No. 12/352,454, filed Jan. 12, 2009
International Application No. PCT/US2008/065398, filed Nov. 20, 2009.
Vilcek, “Novel interferons,” Nature Immunology 4(1):8-9, 2003.

Affiliated with

Also associated with

Rating

Antibodies to interferon-like protein Zcyto21(IL29) does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibodies to interferon-like protein Zcyto21(IL29), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to interferon-like protein Zcyto21(IL29) will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2642481